Men develop a greater risk of cardiovascular disease years earlier than women — starting at around age 35, according to a new long-term study.

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

The number of patients diagnosed with cardiomyopathy has increased substantially over the past two decades. This is the ...

Taking the medication mavacamten for HCM can reduce obstruction in your heart. Learn about its benefits, risks, and side ...

Men start developing heart disease earlier than women, with risks rising faster beginning around age 35, according to ...

A multicentre study shows AI-enabled ECG screening can be integrated into clinical workflows to detect previously undiagnosed hypertrophic cardiomyopathy and accelerate follow-up.

CELEBRATION, Fla. — David Adam Williams, a popular YouTube personality known as “Adam the Woo,” died at the age of 51. He was ...

U.S. track & field star Sydney McLaughlin-Levrone opens up on her pregnancy, her dad's heart disease and a potential Olympic double at the 2028 Games.

Researchers from the U.K. estimated that similar salt reductions in packaged foods and takeout meals could lower daily ...

Together, we’ll explore safe fitness options and practical guidance to help individuals with HCM stay physically active while ...

Deaths from heart disease and stroke are declining, but still kill more Americans than any other cause, according to new data ...